En savoir plus…<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Acticor Biotech obtient le statut “PRIME” de l’Agence Europ\u00e9enne des M\u00e9dicaments pour Glenzocimab dans le traitement de l’AVC Cette jeune soci\u00e9t\u00e9 de biotechnologie au stade clinique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de m\u00e9dicaments innovants pour le traitement des urgences cardio-vasculaires, en particulier l\u2019accident vasculaire c\u00e9r\u00e9bral, annonce avoir re\u00e7u le statut \u201cPRIority Medicines\u201d (PRIME \u2013 m\u00e9dicaments prioritaires) […]<\/p>\n","protected":false},"author":35,"featured_media":32485,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[603],"tags":[],"class_list":["post-32484","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-startup"],"acf":[],"yoast_head":"\n
La start-up Acticor Biotech, accompagn\u00e9e par Ouest Valorisation, obtient le statut "PRIME" de l'Agence Europ\u00e9enne des M\u00e9dicaments - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Thomas Labeyrie\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/\"},\"author\":{\"name\":\"Thomas Labeyrie\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/520a6aec7cf33f5c7ecc4f3936b478f3\"},\"headline\":\"La start-up Acticor Biotech, accompagn\u00e9e par Ouest Valorisation, obtient le statut “PRIME” de l’Agence Europ\u00e9enne des M\u00e9dicaments\",\"datePublished\":\"2022-07-26T14:10:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/\"},\"wordCount\":121,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/acticor-biotech-ouest-valorisation.jpg\",\"articleSection\":[\"Startup\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/\",\"name\":\"La start-up Acticor Biotech, accompagn\u00e9e par Ouest Valorisation, obtient le statut \\\"PRIME\\\" de l'Agence Europ\u00e9enne des M\u00e9dicaments - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/acticor-biotech-ouest-valorisation.jpg\",\"datePublished\":\"2022-07-26T14:10:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/520a6aec7cf33f5c7ecc4f3936b478f3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/acticor-biotech-ouest-valorisation.jpg\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/acticor-biotech-ouest-valorisation.jpg\",\"width\":2560,\"height\":1478,\"caption\":\"acticor biotech ouest valorisation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La start-up Acticor Biotech, accompagn\u00e9e par Ouest Valorisation, obtient le statut \u00ab\u00a0PRIME\u00a0\u00bb de l’Agence Europ\u00e9enne des M\u00e9dicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/520a6aec7cf33f5c7ecc4f3936b478f3\",\"name\":\"Thomas Labeyrie\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/thomas-labeyrieouest-valorisation-fr\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La start-up Acticor Biotech, accompagn\u00e9e par Ouest Valorisation, obtient le statut \"PRIME\" de l'Agence Europ\u00e9enne des M\u00e9dicaments - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/","twitter_misc":{"Written by":"Thomas Labeyrie","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/"},"author":{"name":"Thomas Labeyrie","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3"},"headline":"La start-up Acticor Biotech, accompagn\u00e9e par Ouest Valorisation, obtient le statut “PRIME” de l’Agence Europ\u00e9enne des M\u00e9dicaments","datePublished":"2022-07-26T14:10:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/"},"wordCount":121,"image":{"@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/07\/acticor-biotech-ouest-valorisation.jpg","articleSection":["Startup"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/","url":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/","name":"La start-up Acticor Biotech, accompagn\u00e9e par Ouest Valorisation, obtient le statut \"PRIME\" de l'Agence Europ\u00e9enne des M\u00e9dicaments - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/07\/acticor-biotech-ouest-valorisation.jpg","datePublished":"2022-07-26T14:10:08+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/07\/acticor-biotech-ouest-valorisation.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/07\/acticor-biotech-ouest-valorisation.jpg","width":2560,"height":1478,"caption":"acticor biotech ouest valorisation"},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/la-start-up-acticor-biotech-accompagnee-par-ouest-valorisation-obtient-le-statut-prime-de-lagence-europeenne-des-medicaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"La start-up Acticor Biotech, accompagn\u00e9e par Ouest Valorisation, obtient le statut \u00ab\u00a0PRIME\u00a0\u00bb de l’Agence Europ\u00e9enne des M\u00e9dicaments"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3","name":"Thomas Labeyrie","url":"https:\/\/www.satt.fr\/en\/author\/thomas-labeyrieouest-valorisation-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/32484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=32484"}],"version-history":[{"count":1,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/32484\/revisions"}],"predecessor-version":[{"id":32487,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/32484\/revisions\/32487"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/32485"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=32484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=32484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=32484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}